Mainstay Medical Launches Findings from RESTORE Clinical Trial of ReActiv8 for Chronic Low Back Pain Treatment.

Mainstay Medical Holdings plc has published positive outcomes from the RESTORE clinical trial, demonstrating that ReActiv8 Restorative Neurostimulation therapy significantly improves the treatment of intractable chronic low back pain compared to standard care. The study results validate the effectiveness of ReActiv8 in addressing multifidus dysfunction, offering a new treatment avenue for patients with limited options.